GlassScriptPhysician profile
Sarah Rainwater
NPI 1093212748
$2,061.28
in general payments reported to CMS, 2019-2025
16 companies · $280 in 2025
The $280 reported for 2025 was more than what 83% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.69 · 2022: $20.49 · 2023: $89.02 · 2024: $1,655 · 2025: $280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,070 · Food and Beverage: $954.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,070.25 |
| Food and Beverage | $953.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,363.10 | 2024 | Minimed 780g |
| Collegium Pharmaceutical, INC. | $168.14 | 2025 | Jornay Pm |
| Amgen INC. | $154.54 | 2024 | Evenity, Prolia |
| Ironshore Pharmaceuticals INC. | $57.33 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $51.72 | 2023-2024 | Farxiga, Airsupra |
| Glaxosmithkline, LLC. | $49.46 | 2025 | Bexsero, Penmenvy |
| Sanofi Pasteur INC. | $40.44 | 2024-2025 | |
| Pfizer INC. | $37.75 | 2024-2025 | |
| Inspire Medical Systems, INC. | $22.06 | 2023 | Inspire |
| Dynavax Technologies Corporation | $20.49 | 2022 | |
| Verrica Pharmaceuticals INC. | $18.97 | 2025 | Ycanth |
| Astellas Pharma US INC | $18.79 | 2023 | Veozah |
| Lilly USA, LLC | $16.69 | 2021 | |
| Novo Nordisk INC | $14.71 | 2024 | Ozempic, Rybelsus |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.29 | 2024 | Xifaxan |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $12.80 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Rainwater listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.